We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
49 result(s) found, displaying 1 to 10
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ELADYNOS abaloparatide 2 mg/mL solution for injection cartridge in a prefilled pen.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for YSELTY linzagolix (as choline) 100 mg film coated tablet blister pack.
-
Australian public assessment report (AusPar)Eladynos (abaloparatide) has been approved for the treatment of osteoporosis in postmenopausal women at increased risk of fracture.
-
Prescription medicine registrationActive ingredients: abaloparatide.
-
Prescription medicine registrationActive ingredients: linzagolix choline.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for INTRAROSA prasterone 6.5 mg pessary blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for GANIRELIX THERAMEX ganirelix (as acetate) 250 microgram/0.5 mL solution for injection prefilled syringe.
-
Australian public assessment report (AusPar)Intrarosa (prasterone) has been approved for the treatment of vulvar and vaginal atrophy.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for BIJUVA 1/100 estradiol (as hemihydrate) 1 mg progesterone 100 mg capsule blister pack.
-
Prescription medicine decision summaryTGA decision: Intrarosa (prasterone) is approved to treat vulvar and vaginal atrophy in postmenopausal women.